CORVALLIS, OR--(Marketwire - September 08, 2008) - AVI BioPharma, Inc. (NASDAQ: AVII) announced today that it will host a breakfast meeting for analysts, brokers, investors and the Company’s shareholders on Wednesday, September 10, 2008, from 7:30 a.m. to 10:30 a.m. EDT at the Harvard Club of New York City. AVI’s senior management team will be joined by Dr. Francesco Muntoni, Professor of Pediatric Neurology, University College London Institute of Child Health, and Ben Johnson, Engineering Manager at Global Therapeutics, a Cook Medical Company and partner with AVI in the development of the new GTX drug-eluting stent platform utilizing AVI-5126 for the reduction of cardiovascular restenosis.
